Skip to main content

Movement Disorders Induced by Neuroleptic Drugs

  • Chapter
Movement Disorders

Abstract

Neurology and psychiatry were once considered to be such closely related disciplines that one practitioner commonly treated patients suffering from illnesses of either type. This close relationship has waned, however, and neurologists and psychiatrists now maintain separate journals and professional organizations. Although this separation has advantages, new problems have been created. Nowhere are the problems more evident than in the field of neuropharmacology, where drugs used to treat neurological disease often affect psychiatric function and drugs used to treat psychiatric illness produce neurological symptoms. Behavioral disorders by neurologists and movement disorders by psychiatrists are increasingly reported in their own respective specialty journals. However, clinicians in one area often use vague or technically imprecise terminology when describing the other field. As a result, a psychiatrist reading a neurologist’s report of a behavior or a neurologist reading a psychiatrist’s report of an abnormal movement cannot easily understand the description in terms of classification and presumed pathophysiology or pathogenesis. In this chapter, we hope to contribute to a reciprocal educational effort directed toward ameliorating this problem. This chapter will discuss drug-induced abnormal movements associated with the administration of neuroleptic agents and their classification, description, and pharmacology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ayd, F. J., Jr., 1961a, A survey of drug-induced extrapyramidal reactions, DAMA 175: 1054–1060.

    CAS  Google Scholar 

  • Ayd, F. J., Jr., 1961b, Neuroleptics and extrapyramidal reactions in psychiatric patients, Rev. Can. Biol. 20: 451–459.

    PubMed  CAS  Google Scholar 

  • Barbeau, A., 1978, Phosphatidylcholine (Lecithin) in neuroleptic disorders, Neurology 28: 358.

    Google Scholar 

  • Bartholini, G., Stadler, H., and Lloyd, K. G., 1973, Cholinergic—dopaminergic interactions in the extrapyramidal system, in: Progress in the Treatment of Parkinsonism ( D. B. Caine, ed.), pp. 233–241, Raven Press, New York.

    Google Scholar 

  • Bleuler, E. P., 1951, Textbook of Psychiatry, Dover, New York.

    Google Scholar 

  • Boston Collaborative Drug Surveillance Program, 1973, Drug induced extrapyramidal symptoms: A cooperative study, JAMA 224: 889–891.

    Article  Google Scholar 

  • Brodai, A., 1969, Pathways mediating supraspinal influences on the spinal cord, in: Neurological Anatomy, pp. 151–243, Oxford University Press, New York.

    Google Scholar 

  • Burke, R. E., Fahn, S., Jankovic, J., Marsden, C. D., Lang, A. E., Gollomp, S., and Ilson, J., 1982, Tardive dystonia: Late onset and persistent dystonia caused by antipsychotic drugs, Neurology 32: 1335–1346.

    PubMed  CAS  Google Scholar 

  • Carpenter, M. D., 1976, Human Neuroanatomy, William & Wilkins, Baltimore.

    Google Scholar 

  • Crane, G. E., 1968, Tardive dyskinesias in patients treated with major neuroleptics: A review of the literature, Am. J. Psychiatry. 123 (Feb. Suppl.): 40–48.

    Google Scholar 

  • Crane, G. E., 1974, Factors pre-disposing to drug-induced neurological side effects, in: Advances in Biochemical Psychopharmacology, Vol. 9 ( I. S. Forrest, C. J. Carr, and E. Usdin, eds.), pp. 269–279, Raven Press, New York.

    Google Scholar 

  • Davis, K. L., Berger, P. A., and Hollister, L. E., 1975, Choline for tardive dyskinesia, N. Engl. J. Med. 293: 152.

    PubMed  CAS  Google Scholar 

  • Davis, K. L., Hollister, L. E., Barchas, J. D., and Berger, P. A., 1976, Choline in tardive dyskinesia and Huntington’s disease, Life Sci. 19: 1507–1515.

    Article  PubMed  CAS  Google Scholar 

  • Detre, T. P., and Jarecki, H. G., 1971, Modern Psychiatric Treatment, Lippincott, Philadelphia. Duvoisin, R. C., 1972, Reserpine for tardive dyskinesia, N. Engl. J. Med. 286: 611.

    Google Scholar 

  • Fahn, S., 1983, Treatment of tardive dyskinesia: Use of dopamine depleting agents, Clin. Neuropharmacol. 6: 151–158.

    Article  PubMed  CAS  Google Scholar 

  • Gardos, G., Cole, J. O., and Tarsy, D., 1978, Withdrawal syndromes associated with antipsychotic drugs, Am. J. Psychiatry 135: 1321–1324.

    PubMed  CAS  Google Scholar 

  • Goetz, D. G., and Klawans, H. L., 1984, Tardive dyskinesia, in: Movement Disorders (J. Jankovic, ed.), Neurol. Clin. 2: 605–614.

    Google Scholar 

  • Jaspers, K., 1963, General Psychopathology, pp. 179–185, University of Chicago Press, Chicago.

    Google Scholar 

  • Jus, K., Jus, A., and Gautier, J., 1974, Studies on the action of certain pharmacological agents on tardive dyskinesia and on the rabbit syndrome, Int. J. Clin. Pharmacol. 9: 138–145.

    PubMed  CAS  Google Scholar 

  • Jus, A., Pineau, R., Lanchance, R., Pelchat, G., Jus, K., Pires, P., and Villeneuve, R., 1976, Epidemiology of tardive dyskinesia. Part I, Dis. Nerv. Syst. 37: 210–214.

    PubMed  Google Scholar 

  • Kartzinel, R., and Chase, T. N., 1977, Pharmacology of dystonia, in: Clinical Neuropharmacology, Vol. 2 ( H. L. Klawans, ed.), pp. 43–54, Raven press, New York.

    Google Scholar 

  • Klawans, H. L., Jr., 1968, The pharmacology of parkinsonism: A review, Dis. Nerv. Syst. 29: 805–816.

    PubMed  CAS  Google Scholar 

  • Klawans, H. L., 1973, The Pharmacology of Extrapyramidal Movement Disorders, Karger, Basel. Klawans, H. L., and Rubovits, R., 1972, Central cholingeric—anticholinergic antagonism in Huntington’s chorea, Neurology 22: 107–112.

    Google Scholar 

  • Klawans, H. L., Bergen, D., and Bruyn, G. W., 1973, Prolonged drug induced parkinsonism, Confin. Neurol. 35: 368–377.

    Google Scholar 

  • Klawans, H. L., Carvey, P., Nausieda, P. A., Goetz, C. G., and Weiner, W. J., 1980a, Effect of dose and type of neuroleptic in an animal model of tardive dyskinesia, Neurology 30: 302.

    Google Scholar 

  • Klawans, H. L., Goetz, C. G., and Perlik, S., 1986, Tardive dyskinesia: Review and update, Am. J. Psychiatry 137: 900–908.

    Google Scholar 

  • Korsgaard, S., 1976, Baclofen (Lioresal) in the treatment of neuroleptic-induced tardive dyskinesia, Acta Psychiatr. Scand. 54: 17–24.

    CAS  Google Scholar 

  • Kraepelin, E., 1919, Dementia Praecox and Paraphrenia, Livingstone, Edinburgh.

    Google Scholar 

  • Marsden, C. D., Tarsy, D., and Baldessarini, R. J., 1975, Spontaneous and drug-induced movement disorders in psychiatric patients, in: Psychiatric Aspects of Neurologic Disease ( D. F. Benson and D. Blumer, eds.), pp. 14–32, Grune & Stratton, New York.

    Google Scholar 

  • McDowell, F. H., Lee, J. E., and Sweet, R. D., 1978, Extrapyramidal disease, in: Clinical Neu-rology ( A. B. Baker and L. H. Baker, eds.), pp. 1–67, Harper & Row, Hagerstown, Maryland.

    Google Scholar 

  • Rubovits, R., and Klawans, H. L., 1972, Implication of amphetamine induced stereotyped behavior as a model for tardive dyskinesias, Arch. Gen. Psychiatry 27: 502–507.

    Article  PubMed  CAS  Google Scholar 

  • Selby, G., 1968, Parkinson’s disease, in: Handbook of Clinical Neurology, Diseases of the Basal Ganglia, Vol. 6 ( B. Vinken and G. W. Bruyn, eds.) pp. 173–211, Elsevier North Holland, Amsterdam.

    Google Scholar 

  • Snyder, S. H., Banerjee, S. P., Yamamura, H. I., and Greenberg, D., 1974, Drugs, neurotransmitters and schizophrenia: Phenothiazines, amphetamines, and enzymes synthesizing psychotomimetic drugs aid schizophrenia research, Science 184: 1243–1253.

    Article  PubMed  CAS  Google Scholar 

  • Sovner, R., and Dimascio, A., 1977, The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia, Am. J. Psychiatry 134: 1301–1302.

    PubMed  CAS  Google Scholar 

  • Villeneuve, A., 1972, The rabbit syndrome: A peculiar extrapyramidal reaction, Can. Psychiatr. Assoc. J. 17(Suppl. 2):SS69–72.

    Google Scholar 

  • Weiner, W. J., and Bergen, D., 1977, Prevention and management of the side effects of levodopa, in: Clinical Neuropharmacology, Vol. 2 ( H. L. Klawans, ed.), pp. 1–20, Raven Press, New York.

    Google Scholar 

  • Yaryura-Tobias, J. A., Diamond, B., and Merlis, S., 1972, Psychiatric manifestations of levodopa, Can. Psychiatr. Assoc. J. 17:SS123–128.

    Google Scholar 

  • Young, R. R., and Shahani, B. T., 1979, Pharmacology of tremor, in: Clinical Neuropharmacology, Vol. 4 ( H. L. Klawans, ed.), pp. 139–156, Raven Press, New York.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Publishing Corporation

About this chapter

Cite this chapter

Goetz, C.G., Klawans, H.L., Tanner, C.M. (1986). Movement Disorders Induced by Neuroleptic Drugs. In: Shah, N.S., Donald, A.G. (eds) Movement Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5038-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5038-5_17

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5040-8

  • Online ISBN: 978-1-4684-5038-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics